Gene Query: PI3

Dataset Description Geneva Score
RNAseq of IL-36 stimulated primary human keratinocytes 407.97
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 136.03
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 128.97
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 121.41
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 103.93
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 97.05
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 87.72
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 84.0
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 77.38
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 75.61
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 75.43
Paxillin regulates genomic networks in prostate cancer [PC3] 68.97
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 67.12
Chromatin-informed inference of transcriptional programs in gynecologic cancers 66.25
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 66.25
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 64.07
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 63.87
HNF1 regulates critical functions of the human epididymis epithelium. 63.87
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 62.04
BAF controls genome accessibility 61.63
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 56.75
Region-specific Innate Antiviral Responses of the Human Epididymis 56.56
FOXD3 is a novel tumor suppressor in lung cancer 55.99
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 53.91
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 52.8
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 52.8
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 52.15
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 51.63
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 51.63
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 45.42
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 44.28
Control of prostate tumour growth by the long non-coding RNA GHSROS 43.85
Overexpression and knockdown experiment for circCSNK1G3 41.44
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 39.54
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 38.52
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 37.97
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 37.74
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 37.74
AR-independent prostate cancer is sustained through FGF signaling 37.54
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 37.51
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 36.02
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 36.0
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 35.73
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 34.89
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 34.46
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 34.46
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 34.42
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 33.4
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 33.4
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 32.17
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 31.39
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 31.17
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 30.88
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 30.85
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 29.76
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 28.92
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 28.11
Gene expression changes caused by KRAS in MCF-10A 26.48
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 25.37
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 24.48
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 23.72
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 23.45
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 23.2
Effect of BMP inhibition or stimulation of primary human keratinocytes 23.2
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 23.15
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 23.03
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 22.93
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 22.87
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 22.0
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 21.8
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 21.46
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 20.67
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 20.05
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 20.05
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 19.9
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 19.89
A transcriptome dataset revealing the molecular features of breast cancer stem cells 19.85
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 19.73
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 19.49
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 19.21
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 19.0
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 18.99
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 18.63
circRNA profile in hypopharyngeal cancer 18.05
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 17.9
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 17.77
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 17.51
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 16.29
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 16.29
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  16.15
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 16.14
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 16.02
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 16.0
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 15.89
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 15.89
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 15.58
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 15.53
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 15.53
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 15.32
Splicing and epigenetic factors jointly regulate epidermal differentiation 15.03
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 14.45
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 14.43
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 14.38
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 14.11
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 13.72
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 13.02
Lipid degradation promotes prostate cancer cell survival 12.95
Dysregulated immune system networks in war veterans with PTSD 12.87
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 12.81
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 12.3
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 12.3
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 12.12
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 12.04
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 11.79
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 11.79
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 11.71
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 11.71
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 11.68
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 11.6
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 11.34
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 11.34
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 11.3
Mutational landscape of splicing genes and functional consequences across 33 cancer types 10.79
Differetially expressed genes after hTR overexpression in U2OS cells 10.68
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 10.57
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.5
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.5
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 10.5
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.45
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 10.36
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 10.36
EWS-Fli and LNC regulated genes in comparison to GFP samples 10.3
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 10.1
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 9.95
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 9.85
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 9.85
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 9.62
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 9.61
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 9.56
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 9.44
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 9.43
Defective structural RNA processing in relapsing-remitting multiple sclerosis 9.34
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 9.22
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 9.1
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 8.75
UBC9 knockdown in bladder cancer T24 cell lines 8.62
MRTF activates TEAD-YAP target gene expression 8.57
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 8.46
Transcriptome of diurnal human blood neutrophils 8.36
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 8.35
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 8.28
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 8.18
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 8.09
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 8.08
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 8.08
mRNA sequencing of oropharyngeal cancer cell lines 8.07
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  7.97
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 7.94
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 7.78
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 7.77
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 7.75
Investigate A2M treatment on human prostate cancer and mouse liver 7.72
Investigate A2M treatment on human prostate cancer xenograft in mice 7.72
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 7.62
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 7.61
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 7.41
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 7.4
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 7.3
Selective expression of long non-coding RNAs in a breast cancer cell progression model 7.25
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 7.1
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 6.89
Differentially expressed genes post knock down of lincDUSP26 6.83
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 6.81
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 6.71
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 6.71
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 6.67
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 6.66
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 6.51
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 6.41
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 6.38
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 6.17
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 6.17
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 6.11
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 5.98
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 5.98
Human neutrophil genome during PMA- and E. coli encounter-induced activation 5.98
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 5.98
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.95
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 5.95
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 5.94
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 5.94
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 5.89
The Genomic Landscape of Atypical Fibroxanthoma 5.87
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 5.83
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 5.71
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 5.53
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.48
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 5.37
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.31
RNA-sequencing 5.25
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 5.21
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 5.16
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 5.15
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 5.07
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 5.04
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.01
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.01
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 5.01
RNA-seq analysis and shRNA screen of breast cancer 5.01
RNA-seq analysis of breast cancer 5.01
Tpl-2 and MEK small molecule inhibitors 4.97
Tpl-2 small molecule project 4.97
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 4.89
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 4.85
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.74
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.74
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 4.69
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 4.69
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.53
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 4.47
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 4.47
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 4.44
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 4.44
RNA-Seq analysis of human colorectal cancer with liver metastasis 4.43
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 4.43
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 4.39
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 4.36
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 4.22
Controlling for gene expression changes in transcription factor protein networks. 4.13
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 4.11
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 4.06
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 4.01
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 4.01
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 3.88
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 3.88
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.87
Downregulation of LATS kinases alters p53 to promote cell migration 3.86
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 3.83
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 3.83
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 3.83
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 3.81
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 3.81
RNA-sequencing in immortalized human mammary epithelial cells 3.78
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 3.78
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 3.75
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.74
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.73
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.72
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 3.7
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 3.66
RNA seq analysis of human Fetal and adult derived Enterospheres 3.54
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 3.53
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.47
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 3.45
Regulatory network controlling tumor-promoting inflammation in human cancers 3.43
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.43
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 3.43
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 3.41
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.4
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.36
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 3.32
Gene expression alterations of pancreatic intraepithlial neoplasia 3.27
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 3.24
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 3.24
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 3.16
SLIGRL-induced gene expression changes in NHEK cells 3.08
RNA-seq analyses of human prostate cancer cells 3.02
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 2.93
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.84
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.83
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.83
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.8
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.8
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 2.73
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 2.73
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 2.73
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 2.69
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.68
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.67
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.67
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.62
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.6
RNA-seq analyisis of PUM2 knockout cells 2.49
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 2.44
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.41
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 2.4
RNA Sequencing of three pairs of gastric cancer 2.33
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.33
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.31
ML29755 RNA-seq data 2.31
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.31
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 2.26
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.23
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 2.21
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 2.21
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 2.18
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 2.18
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 2.14
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 2.14
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 2.12
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.08
Transcriptome analysis of virus infected tissues 2.08
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.07
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 2.06
p63 controls the enhancer landscape during keratinocyte differentiation 2.06
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 2.04
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 2.02
Gene expression analysis of human liver progenitor-like cells in culture 2.02
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 2.01
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.0
Reprogrammed myeloid cell transcriptomes in NSCLC 1.97
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.95
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.94
Expression analysis of the TAF1 syndrome 1.92
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 1.91
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 1.91
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.87
Effect of nuclear IL-33 on gene expression 1.85
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 1.79
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.75
RNA-Seq and expression data from human adipose tissue 1.75
MCF10A H-Ras RNA-Seq 1.74
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.73
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.73
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.71
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.7
Transcriptomic analysis of frontal fibrosing alopecia 1.65
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 1.55
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 1.54
Identification of a LIF-responsive replication-competent human β cell 1.52
Noncoding regions are the main source of targetable tumor-specific antigens 1.52
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 1.51
Gene expression analysis of immortalized human liver progenitor-like cells in culture 1.5
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 1.49
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 1.47
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.46
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.45
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.45
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 1.41
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 1.41
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.4
A practical evaluation of alignment algorithms for RNA variant calling analysis 1.4
Fusion discovery in breast cancer cell line 1.38
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.37
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.36
Effect of Influenza virus infection on lncRNA expression in A549 cells 1.36
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.32
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.31
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.3
RNA-seq of IL-4 stimulated human keratinocytes 1.28
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 1.27
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 1.26
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.24
RNA-sequencing of formalin fixed human primary melanoma tissue 1.23
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 1.17
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 1.1
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.1
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.1
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 1.03
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 1.03
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 1.02
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 1.01
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.01
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 0.99
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.99
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.95
Accurate annotation of human protein-coding small open reading frames 0.94
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.94
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 0.93
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.92
Single cell transcriptome of peritoneal cells 0.92
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.92
MYCi975 regulates MYC target genes 0.91
Clinker: visualizing fusion genes detected in RNA-seq data 0.91
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.9
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.89
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.88
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.87
Molecular analysis of renal cell carcinoma with unclassfied histology 0.87
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.85
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.84
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 0.83
RNA sequencing of human pancreatic cancer cell lines 0.83
Role of cervicovaginal microbiota in genital inflammation 0.82
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.82
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.82
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 0.8
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.79
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 0.79
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 0.79
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.79
RNA editing in nascent RNA affects pre-mRNA splicing 0.78
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.75
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.74
Gene expression analysis of human adenomas. 0.74
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 0.72
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.71
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 0.71
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.71
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.7
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.7
Non-coding regions are the main source of tumor-specific antigens [human] 0.69
Non-coding regions are the main source of tumor-specific antigens 0.69
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.69
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.66
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.65
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 0.62
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.61
The Glioma-Infiltrating T Cell Receptor Repertoire 0.61
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.6
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 0.6
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 0.6
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 0.6
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 0.58
RNA-seq in endometrial stromal tumors 0.58
Transcriptome analysis of human lung epithelial cells 0.58
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.55
The expression profiles of GBC liver metastasis 0.55
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.53
An optimization system for isolating and sequencing of single human colon cancer cells 0.53
Anti-inflammatory effect of indoleacrylic acid (IA) 0.52
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 0.52
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.51
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.5
Analysis of transcriptional regulation by Myt1 and Myt1l 0.49
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.48
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.48
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.48
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.47
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 0.46
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 0.46
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.45
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.45
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.44
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.44
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.44
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.43
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 0.41
Epigenome regulation during epidermal lineage commitment 0.4
LncRNA expression profiling of ischemic stroke patients 0.39
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.39
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.37
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 0.37
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.35
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.34
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.32
Gene expression of collecting duct carcinoma of the kidney 0.32
RNA sequencing of human mammary epithelial cells 0.32
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.32
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 0.31
A single-cell transcriptome atlas of the human pancreas 0.31
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 0.31
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.3
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.29
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.27
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 0.27
The circadian transcriptional landscape in primary human mammary epithelial cells 0.26
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 0.26
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.24
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.23
Gene expression analysis of human hepatocellular cancers 0.23
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.21
RNA-Seq of PRMT1 overexpression ECA109 cells 0.19
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.19
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.19
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.19
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.19
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.19
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.18
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.17
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.17
Human islets of varying quality: the good, the (not so) bad and the ugly 0.16
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.14
RNA seq_PDX2_SHP099 0.14
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.13
Common inflammatory pathways between NEC and Crohn's disease 0.13
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.12
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.12
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.12
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 0.12
The gene expression profiles of gallbladder cancer 0.12
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.11
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.11
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.1
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.1
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.1
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.1
Discovering human diabetes-risk gene function with genetics and physiological assays 0.09
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 0.08
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.06
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.06
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.05
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.04
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.03
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.03
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.02
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.02
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.02
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.01
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation